The outlook of companies tied to Viagra's legacy presents a challenging investment scenario . While the initial surge generated substantial profits , generic competition have significantly eroded market share . Investing in related pharmaceutical firms now requires a careful assessment of intellectual property rights , evolving healthcare click her